等待开盘 04-02 09:30:00 美东时间
0.000
0.00%
Cyclerion Therapeutics has received positive regulatory feedback from the FDA for its Phase 2 POC study of CYC-126 for treatment-resistant depression (TRD). CYC-126, an anesthetic-based therapy using real-time EEG feedback, aims to address TRD through individualized, precision delivery. The FDA supports the study design, leveraging approved anesthetics, allowing Cyclerion to remain on track to initiate the trial in late 2026. Additionally, the co...
02-17 12:00
Celsion (NASDAQ:CLSN) announced Monday its decision to change company's name to...
2022-09-20 04:43
北京时间2022年09月19日22时03分,克莱瑞恩(CLSN.us)股票出现异动,股价大幅跳水5.39%。截至发稿,该股报1.93美元/股,成交量1.552...
2022-09-19 22:53
Celsion (NASDAQ:CLSN – Get Rating) and Supernus Pharmaceuticals (NASDAQ:SUPN – ...
2022-09-15 16:22
北京时间2022年09月01日22时05分,克莱瑞恩(CLSN.us)股票出现波动,股价大幅跳水5.63%。截至发稿,该股报2.01美元/股,成交量2.621万...
2022-09-01 22:54
北京时间2022年08月20日03时32分,克莱瑞恩(CLSN.us)股票出现波动,股价快速下跌5.06%。截至发稿,该股报2.30美元/股,成交量4.606...
2022-08-20 03:54
Celsion (NASDAQ:CLSN – Get Rating) announced its quarterly earnings data on Mon...
2022-08-18 06:41
北京时间2022年08月05日21时34分,克莱瑞恩(CLSN.us)股票出现波动,股价大幅下跌6.69%。截至发稿,该股报2.37美元/股,成交量1.165...
2022-08-05 21:55
Celsion Co. (NASDAQ:CLSN – Get Rating) was the target of a large drop in short ...
2022-08-03 16:41
北京时间2022年07月27日23时41分,克莱瑞恩(CLSN.us)股票出现波动,股价快速跳水5.29%。截至发稿,该股报2.15美元/股,成交量2.711...
2022-07-28 00:54